- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By 
Kyle Brasseur2020-02-20T16:18:00
A high-ranking member of the Department of Justice’s Antitrust Division addresses a recent policy change that evaluates corporate compliance programs as a potential leniency factor in antitrust cases.
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
A Justice Department policy change–to evaluate corporate compliance programs as a potential leniency factor on antitrust cases–has come to fruition through announcements made this week.
Justice Department Principal Deputy Associate Attorney General Claire McCusker Murray spoke at CW’s annual conference on how the agency’s Civil Division seeks to motivate compliance.
GeneDx, which delivers personalized and actionable health insights to inform diagnosis, direct treatment, and improve drug discovery, announced the appointment of Heidi Chen as chief legal officer.
The Department of Justice has added antitrust compliance guidance in an update to its Evaluation of Corporate Compliance Programs.
Change is likely coming to the Securities and Exchange Commission’s enforcement priorities with the pending handover of the White House to Republican President-elect Donald Trump. Adjust your compliance priorities accordingly.
Dr. Mehmet Oz, President-elect Donald Trump’s pick to lead the Centers for Medicare and Medicaid Services, has a mandate from Trump to “take on the illness industrial complex” and to cut costs.
